For all inquiries regarding Tissue Microarrays with survival data, please contact us at support@arraysbank.com
home > TISSUE ARRAYS > Prostate > MPR484
tissue microarray-MPR484
  • Cores:
    48
    CASES:
    27
    Core Diameter(mm):
    1.5
    Thickness(µm):
    5
    Row number:
    6
    Column number:
    8
    Tissue Array Type:
    FFPE
    Species:
    Human
MPR484
$265.00
Add To Collect

Description: Metastatic prostate cancer tissue array, including TNM and clinical stage, 27 cases/48 cores

Details: Metastatic prostate cancer tissue microarray, containing 27 cases metastatic adenocarcinoma, single core per case or duplicate core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Rig-Right pelvic lymph nodes Lef-Left pelvic lymph nodes Pel-Pelvic lymph nodes Lef-Left femur Tho-Thoracic vertebra 9 Pel-Pelvis Rig-Right femur Tho-Thoracic vertebra 1 Tho-Thoracic vertebra 10 Rig-Right acetabulum Lef-Left iliac artery
  • Malignant(IV)
  • _ma
https://www.arraysbank.com/tissue-arrays

TISSUE ARRAYS
MPR484
1
2
3
4
5
6
7
8
A
Rig
Rig
Rig
Rig
Lef
Lef
Rig
Rig
B
Pel
Pel
Lef
Lef
Rig
Rig
Pel
Pel
C
Rig
Rig
Lef
Lef
Lef
Lef
Pel
Pel
D
Lef
Lef
Lef
Lef
Tho
Tho
Pel
Pel
E
Lef
Lef
Rig
Rig
Lef
Lef
Tho
Tho
F
Pel
Pel
Tho
Rig
Rig
Rig
Lef
Lef
_ma
MPR484
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Gleason Grade Gleason Score
A1
1 66 M Right pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T3bN1M0 IV Malignant 3 4+3=7
A2
2 66 M Right pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T3bN1M0 IV Malignant 3 4+3=7
A3
3 63 M Right pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T3bN1M0 IV Malignant 5 5+5=10
A4
4 63 M Right pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T3bN1M0 IV Malignant 5 5+5=10
A5
5 60 M Left pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T2cN1M0 IV Malignant 5 4+5=9
A6
6 60 M Left pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T2cN1M0 IV Malignant 5 4+5=9
A7
7 66 M Right pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T3bN1M0 IV Malignant 5 5+5=10
A8
8 66 M Right pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T3bN1M0 IV Malignant 5 5+5=10
B1
9 62 M Pelvic lymph nodes Metastatic prostatic acinar cell carcinoma (fibrous tissue) * T3bN1M0 IV Malignant 5 4+5=9
B2
10 62 M Pelvic lymph nodes Metastatic prostatic acinar cell carcinoma (fibrous tissue) * T3bN1M0 IV Malignant 5 4+5=9
B3
11 66 M Left pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T2cN1M0 IV Malignant 5 4+5=9
B4
12 66 M Left pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T2cN1M0 IV Malignant 5 4+5=9
B5
13 63 M Right pelvic lymph nodes Metastatic prostatic acinar cell carcinoma with neuroendocrine differentiation * T4N1M0 IV Malignant 5 5+5=10
B6
14 63 M Right pelvic lymph nodes Metastatic prostatic acinar cell carcinoma with neuroendocrine differentiation * T4N1M0 IV Malignant 5 5+5=10
B7
15 61 M Pelvic lymph nodes Metastatic prostatic acinar cell carcinoma with neuroendocrine differentiation * T3bN1M0 IV Malignant 5 5+4=9
B8
16 61 M Pelvic lymph nodes Metastatic prostatic acinar cell carcinoma with neuroendocrine differentiation * T3bN1M0 IV Malignant 5 5+4=9
C1
17 74 M Right pelvic lymph nodes Metastatic prostatic acinar cell carcinoma with neuroendocrine differentiation * T2bN1M0 IV Malignant 5 4+5=9
C2
18 74 M Right pelvic lymph nodes Metastatic prostatic acinar cell carcinoma with neuroendocrine differentiation * T2bN1M0 IV Malignant 5 4+5=9
C3
19 70 M Left pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T3bN1M0 IV Malignant 5 4+5=9
C4
20 70 M Left pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T3bN1M0 IV Malignant 5 4+5=9
C5
21 47 M Left pelvic lymph nodes Metastatic prostatic acinar cell carcinoma with neuroendocrine differentiation (sparse) * T3bN1M0 IV Malignant 5 5+4=9
C6
22 47 M Left pelvic lymph nodes Metastatic prostatic acinar cell carcinoma with neuroendocrine differentiation * T3bN1M0 IV Malignant 5 5+4=9
C7
23 60 M Pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T3bN1M0 IV Malignant 5 5+4=9
C8
24 60 M Pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T3bN1M0 IV Malignant 5 5+4=9
D1
25 68 M Left femur Metastatic prostatic acinar cell carcinoma with neuroendocrine differentiation * TxNxM1b IV Malignant 5 5+5=10
D2
26 68 M Left femur Metastatic prostatic acinar cell carcinoma with neuroendocrine differentiation * TxNxM1b IV Malignant 5 5+5=10
D3
27 62 M Left femur Metastatic prostatic acinar cell carcinoma * TxNxM1b IV Malignant 4 4+4=8
D4
28 62 M Left femur Metastatic prostatic acinar cell carcinoma * TxNxM1b IV Malignant 4 4+4=8
D5
29 68 M Thoracic vertebra 9 Metastatic prostatic acinar cell carcinoma * TxNxM1b IV Malignant 5 4+5=9
D6
30 68 M Thoracic vertebra 9 Metastatic prostatic acinar cell carcinoma * TxNxM1b IV Malignant 5 4+5=9
D7
31 / M Pelvis Metastatic prostatic acinar cell carcinoma (necrosis) * TxNxM1b IV Malignant / /
D8
32 / M Pelvis Metastatic prostatic acinar cell carcinoma (sparse) * TxNxM1b IV Malignant / /
E1
33 64 M Left pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T3bN1M0 IV Malignant 4 4+4=8
E2
34 64 M Left pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T3bN1M0 IV Malignant 4 4+4=8
E3
35 59 M Right femur Metastatic prostatic acinar cell carcinoma * TxNxM1b IV Malignant 5 4+5=9
E4
36 59 M Right femur Metastatic prostatic acinar cell carcinoma * TxNxM1b IV Malignant 5 4+5=9
E5
37 79 M Left pelvic lymph nodes Metastatic prostatic acinar cell carcinoma with neuroendocrine differentiation * T3bN1M0 IV Malignant 5 5+4=9
E6
38 79 M Left pelvic lymph nodes Metastatic prostatic acinar cell carcinoma with neuroendocrine differentiation * T3bN1M0 IV Malignant 5 5+4=9
E7
39 85 M Thoracic vertebra 1 Metastatic prostatic acinar cell carcinoma * TxNxM1b IV Malignant 5 5+4=9
E8
40 85 M Thoracic vertebra 1 Metastatic prostatic acinar cell carcinoma * TxNxM1b IV Malignant 5 5+4=9
F1
41 / M Pelvis Metastatic prostatic acinar cell carcinoma (sparse) * TxNxM1b IV Malignant 5 5+4=9
F2
42 / M Pelvis Metastatic prostatic acinar cell carcinoma with necrosis (sparse) * TxNxM1b IV Malignant 5 5+4=9
F3
43 58 M Thoracic vertebra 10 Metastatic prostatic acinar cell carcinoma (sparse) * TxNxM1b IV Malignant 5 5+5=10
F4
44 50 M Right pelvic lymph nodes Metastatic prostatic acinar cell carcinoma (sparse) * T2cN1M0 IV Malignant 5 4+5=9
F5
45 58 M Right pelvic lymph nodes Metastatic prostatic acinar cell carcinoma * T3bN1M0 IV Malignant 5 4+5=9
F6
46 / M Right acetabulum Metastatic prostatic acinar cell carcinoma * TxNxM1b IV Malignant 5 5+4=9
F7
47 70 M Left iliac artery Metastatic prostatic acinar cell carcinoma * T4N1M0 IV Malignant 5 5+4=9
F8
48 70 M Left iliac artery Metastatic prostatic acinar cell carcinoma * T4N1M0 IV Malignant 5 5+4=9
_marker_
Find overlapping cases with this tissue array:
For all inquiries regarding product specifications, please contact us at support@arraysbank.com
0.275315s